PATEL EXPORT INDUSTRIES
GST : 24AIRPL2393L1ZP

Call us now :08045817028

Send Inquiry

GLYNEUTOL MANNITOL 10%W/V & GLYCERIN 10%W/V I.V. INFUSION

Send Inquiry

Request To Call Back

GLYNEUTOL MANNITOL 10%W/V & GLYCERIN 10%W/V I.V. INFUSION

Get a Price/Quote

GLYNEUTOL MANNITOL 10%W/V & GLYCERIN 10%W/V I.V. INFUSION Specification

Salt Composition
Mannitol 10% w/v, Glycerin 10% w/v

Dosage Form
Injection/IV Infusion

Pacakaging (Quantity Per Box)
1 bottle per box

Indication
Cerebral edema, glaucoma, acute renal failure

Origin of Medicine
Allopathic

Drug Type
Parenteral Solution

Ingredients
Mannitol 10% w/v, Glycerin 10% w/v

Physical Form
Liquid

Function
Osmotic diuretic and dehydrating agent

Recommended For
Adjuvant therapy in cerebral edema, elevated intraocular and intracranial pressure, renal failure

Dosage
As prescribed by physician; typically administered intravenously

Dosage Guidelines
Administer by slow intravenous infusion

Suitable For
Adults

Quantity
100 ml

Storage Instructions
Store below 25°C, protect from light, do not freeze

Regulatory Certification
GMP Certified

Appearance
Clear, colorless, sterile solution

Side Effects
Fluid/electrolyte imbalance, headache, nausea, vomiting

Usage Route
Intravenous infusion

Shelf Life
24 months from manufacture

Container Type
Glass bottle

Brand Name
Glyneutol

Contraindications
Hypersensitivity, anuria, severe dehydration, pulmonary edema

GLYNEUTOL MANNITOL 10%W/V & GLYCERIN 10%W/V I.V. INFUSION Trade Information

Supply Ability
100 Per Day

Delivery Time
7 Days

Sample Available
No

Sample Policy
Contact us for information regarding our sample policy

About GLYNEUTOL MANNITOL 10%W/V & GLYCERIN 10%W/V I.V. INFUSION

Strength	10 %
Pack Size	100 ml
Packaging Type	Bottle
Pack Type	Box
Brand Name	GLYNEUTOL
Manufactured By	Neon Laboratories Ltd
Country of Origin	Made in India
Minimum Order Quantity	100 Piece

GLYNEUTOL
MANNITOL 10%W/V & GLYCERIN 10%W/V I.V. INFUSION

Dual Action Osmotic Therapy

Glyneutol combines Mannitol and Glycerin to offer a potent, rapid-acting osmotic diuretic solution. This dual action aids in reducing excess fluid accumulation, effectively managing cerebral edema and elevated intraocular or intracranial pressure. The clear, colorless sterile solution is formulated for optimal safety and efficacy in urgent clinical scenarios.

Strict Quality and Safety Assured

Produced in GMP Certified facilities, Glyneutol undergoes stringent quality control to ensure sterility, purity, and consistent therapeutic effect. Every 100 ml infusion is delivered in a sealed glass bottle, maintaining its integrity and preventing contamination. Its 24-month shelf life ensures reliable availability in medical settings.

Convenient Administration and Storage

Designed for slow intravenous infusion, Glyneutol ensures controlled and precise delivery. Storage below 25C and protection from light preserves its stability and effectiveness. The clear labeling and single-use packaging provide healthcare professionals with straightforward handling and dosing.

FAQ's of GLYNEUTOL MANNITOL 10%W/V & GLYCERIN 10%W/V I.V. INFUSION:

Q: How is Glyneutol administered to patients?

A: Glyneutol is administered by slow intravenous infusion, typically in a hospital or clinical setting under the supervision of qualified healthcare professionals. The dosage and duration are determined by the physician, tailored to the patient's specific medical needs.

Q: What conditions is Glyneutol recommended for?

A: Glyneutol is primarily used as adjuvant therapy in the management of cerebral edema, elevated intraocular and intracranial pressure, and acute renal failure. Its osmotic diuretic properties help alleviate these conditions effectively.

Q: What are the main benefits of using Glyneutol IV Infusion?

A: Glyneutol provides rapid reduction of fluid overload in cases such as cerebral edema and glaucoma. Its combination of Mannitol and Glycerin ensures efficient osmotic action, improving patient outcomes in acute medical situations.

Q: Who should avoid receiving Glyneutol infusion?

A: Glyneutol is contraindicated in individuals with known hypersensitivity to its ingredients, anuria, severe dehydration, or pulmonary edema. It should only be used when clearly indicated and prescribed by a physician.

Q: What side effects may occur with Glyneutol treatment?

A: Possible side effects of Glyneutol include fluid and electrolyte imbalance, headache, nausea, and vomiting. Medical professionals closely monitor patients during and after administration to manage and mitigate any adverse reactions.

Q: How should Glyneutol be stored before use?

A: Glyneutol must be stored below 25C, protected from light, and should not be frozen. Proper storage ensures the product remains sterile and effective throughout its 24-month shelf life.

Q: What process ensures the safety and quality of Glyneutol?

A: Glyneutol is manufactured in facilities certified under Good Manufacturing Practices (GMP), guaranteeing rigorous quality control, sterility, and safety from production to packaging.

Tell us about your requirement